These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24795909)

  • 1. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD?
    Hamilton T; Miller JB; Vincent EC; St Anna L
    J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of inhaled corticosteroids in the management of COPD].
    Chazan R
    Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
    Wang ZL
    Chin Med J (Engl); 2007 Jun; 120(12):1097-105. PubMed ID: 17637229
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled corticosteroids in severe COPD.
    Bousquet J
    Lancet Respir Med; 2013 May; 1(3):177-8. PubMed ID: 24429112
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
    Jones PW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):689-90. PubMed ID: 19805796
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effectiveness of synergic therapy].
    Płusa T; Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of inhaled corticosteroids in COPD].
    Kamoi H; Yoshikawa T; Hirata K
    Nihon Rinsho; 2007 Apr; 65(4):696-701. PubMed ID: 17419390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled combination therapy with corticosteroids and long-acting beta-2 agonists in chronic obstructive pulmonary disease].
    Chen YH; Yao WZ; Zhao MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):928-30. PubMed ID: 19134412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhalation steroids in COPD: of value only for asthma patients!].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(44):16. PubMed ID: 14655500
    [No Abstract]   [Full Text] [Related]  

  • 15. Life in the COPD straitjacket: improving lives of sufferers.
    Booker R
    Br J Nurs; 2003 Oct 9-22; 12(18):1061. PubMed ID: 14581837
    [No Abstract]   [Full Text] [Related]  

  • 16. The benefits of combined treatment with corticosteroids and long-acting beta agonists.
    Singh D
    Int J Chron Obstruct Pulmon Dis; 2006; 1(3):207-8. PubMed ID: 18046857
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management--inhaled treatment.
    Currie GP; Lipworth BJ
    BMJ; 2006 Jun; 332(7555):1439-41. PubMed ID: 16777889
    [No Abstract]   [Full Text] [Related]  

  • 19. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD; Man SF
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids in COPD: the final verdict is….
    Leung JM; Sin DD
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30545961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.